US · Healthcare

Cannabis Global Inc (CBGL)

Drug Manufacturers - Specialty & Generic

Cannabis Global Inc (CBGL) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CBGL

P/E ratio

18.00

Cannabis Global Inc (CBGL) — FAQ

What is CBGL's P/E ratio?

The price-to-earnings (P/E) ratio for Cannabis Global Inc (CBGL) is 18.00 (data as of 2026-05-23).

Does Cannabis Global Inc pay a dividend?

Dividend yield is not available in the current snapshot for Cannabis Global Inc (CBGL). Check the MyAverix Finance app for the latest dividend data.

What sector is Cannabis Global Inc in?

Cannabis Global Inc (CBGL) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CBGL listed on?

CBGL is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)